| Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology DE Ribeiro, Á Oliveira-Giacomelli, T Glaser, VF Arnaud-Sampaio, ... Molecular psychiatry 26 (4), 1044-1059, 2021 | 113 | 2021 |
| The P2X7 receptor: central hub of brain diseases R Andrejew, Á Oliveira-Giacomelli, DE Ribeiro, T Glaser, ... Frontiers in Molecular Neuroscience 13, 124, 2020 | 111 | 2020 |
| Role of P2X7 receptors in immune responses during neurodegeneration Á Oliveira-Giacomelli, LL Petiz, R Andrejew, N Turrini, JB Silva, U Sack, ... Frontiers in cellular neuroscience 15, 662935, 2021 | 29 | 2021 |
| Purinergic receptors in basal ganglia diseases: shared molecular mechanisms between Huntington’s and Parkinson’s disease T Glaser, R Andrejew, A Oliveira-Giacomelli, DE Ribeiro, ... Neuroscience bulletin 36, 1299-1314, 2020 | 26 | 2020 |
| Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients AJ Pietrobon, R Andrejew, RWA Custódio, LM Oliveira, JN Scholl, ... Frontiers in immunology 13, 1012027, 2022 | 19 | 2022 |
| Lithium-induced neuroprotective activity in neuronal and microglial cells: A purinergic perspective C Gubert, R Andrejew, F Figueiro, L Bergamin, F Kapczinski, ... Psychiatry research 295, 113562, 2021 | 11 | 2021 |
| P2X7 purinergic receptor is involved in the pathophysiology of mania: a preclinical study C Gubert, R Andrejew, CE Leite, CEJ Moritz, J Scholl, F Figueiro, ... Molecular Neurobiology 57, 1347-1360, 2020 | 11 | 2020 |
| Bipolar disorder and 1513A> C P2RX7 polymorphism frequency C Gubert, R Andrejew, CEJ Moritz, F Dietrich, MP Vasconcelos-Moreno, ... Neuroscience letters 694, 143-147, 2019 | 10 | 2019 |
| Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease DE Ribeiro, LL Petiz, T Glaser, Á Oliveira-Giacomelli, R Andrejew, ... Neuropharmacology 226, 109371, 2023 | 9 | 2023 |
| Effects of N-acetylcysteine on amphetamine-induced sensitization in mice AP Herrmann, R Andrejew, R Benvenutti, CS Gama, E Elisabetsky Brazilian Journal of Psychiatry 40, 169-173, 2017 | 8 | 2017 |
| The purinergic system as a target for the development of treatments for bipolar disorder MCB Gonçalves, R Andrejew, C Gubert Cns Drugs 36 (8), 787-801, 2022 | 7 | 2022 |
| Mesenchymal stem cell‐glioblastoma interactions mediated via kinin receptors unveiled by cytometry MM Pillat, Á Oliveira‐Giacomelli, M das Neves Oliveira, R Andrejew, ... Cytometry Part A 99 (2), 152-163, 2021 | 7 | 2021 |
| Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases R Andrejew, T Glaser, Á Oliveira-Giacomelli, D Ribeiro, M Godoy, ... Stem Cells: Therapeutic Applications, 275-353, 2019 | 7 | 2019 |
| High P2X6 receptor expression in human bladder cancer predicts good survival prognosis F Dietrich, AR Cappellari, EC Filippi-Chiela, PB de Paula, JB de Souza, ... Molecular and Cellular Biochemistry 477 (8), 2047-2057, 2022 | 6 | 2022 |
| Post-weaning social isolation impairs purinergic signaling in rat brain R Andrejew, M Paim, CEJ Moritz, F Carreño, SMK Rates, E Elisabetsky, ... Neurochemistry International 148, 105111, 2021 | 6 | 2021 |
| Mapping the content of comments on bioRxiv and medRxiv preprints CFD Carneiro, G Costa, K Neves, MB Abreu, PB Tan, D Rayêe, F Boos, ... bioRxiv, 2022.11. 23.517621, 2022 | 5 | 2022 |
| Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases T Glaser, Á Oliveira-Giacomelli, LL Petiz, DE Ribeiro, R Andrejew, ... Frontiers in Pharmacology 12, 659097, 2021 | 4 | 2021 |
| Glioblastoma cell invasiveness and epithelial-to-mesenchymal transitioning are modulated by kinin receptors MN Oliveira, MM Pillat, J Baranova, R Andrejew, BL dos Santos, SL Costa, ... Advances in Cancer Biology-Metastasis 4, 100045, 2022 | 3 | 2022 |
| Characterization of comments about bioRxiv and medRxiv preprints CFD Carneiro, GG da Costa, K Neves, MB Abreu, PB Tan, D Rayêe, ... JAMA Network Open 6 (8), e2331410-e2331410, 2023 | 2 | 2023 |
| Exploring CD39 and CD73 expression as potential biomarkers in prostate cancer CFF Gardani, EL Pedrazza, VS Paz, GG Zanirati, JC da Costa, ... Pharmaceuticals 16 (11), 1619, 2023 | | 2023 |
